Medical researchers are continuously forging new ground, reaching and exceeding goals that once seemed a long way off or even impossible. The rate at which discovery and medical advancement occurs is exponential. A primary goal of medical research is to extend the life and quality of life for the population.
The challenge for researchers is gaining access to sufficient funding – which is vital to continue their excellent work – discovering new and innovative ways to make a real difference in people’s lives.
With a variety of organisations vying for research funding from government agencies and industry bodies, the battle for medical devices to receive a fair proportion of funding is as keenly contested as ever.
Medical research contributes to the development of new treatments that can prevent diseases and help sick and injured people. Treating people requires knowledge of several biological, behavioural and social factors. Medical research allows physicians, doctors and medical professionals to gain a greater understanding into how our bodies work, why we become ill, what we can do to get better and how we can bounce back from injuries to live our lives to the fullest.
Research has eradicated many conditions that were once life threatening however much work is still to be done.
In the US the federal government plays a key role in funding medical research through the National Institutes of Health (NIH). The NIH is a part of the Department of Health and Human Services and is made up of 27 different institutes and centres which have their own distinct manifesto. Each institute often focuses on a particular area of medicine.
The funding provided through the NIH is invaluable for researchers throughout the US.
In Ireland, where Trulife is headquartered, the Health Research Board (HRB) provides a significant amount of funding. In 2017, 115 funds were awarded to different research projects with some fantastic results – one such project related to addressing heart failure. Over 3,000 Irish patients benefited from this project that aimed to prevent heart failure and help to reduce hospital admissions by over 17,250 each year.
Another big success story in Ireland was announced recently as Irish scientists made a big breakthrough in breast cancer research. A team at NUIG have identified a potential drug that reduces cancer and helps improve treatment through improving the effectiveness of the initial chemotherapy treatment and reducing relapse rates.
The SFI CÚRAM Centre for Research in Medical Devices also provides funding in Ireland and supports research into innovative smart medical devices that will be able to help patients with problems including cardiovascular, musculoskeletal, neural, soft tissue, renal and urology and respiratory health issues.
Horizon 2020 is a big EU wide research programme that began in 2014 and runs through to 2020. Almost €80 billion was set aside for funding during this period and it has helped drive major breakthroughs and discoveries.
Medical Devices have an advantage in a number of areas when competing for funding in that there can be less rigorous FDA approval requirements for devices as opposed to drugs. There is also lower cost of trials, lower pricing and profitability of products. And there’s a more predictable influence of new technology due to a limited number of competitors.
Medical devices manufacturers will need to continue to develop innovative products that can create positive change in people’s lives ensuring they continue to be top of mind when applying for funding.
Medical devices play an extremely important role in todays society as they greatly enhance the quality of life for the people that use them. In the US the FDA recently announced their Medical Device Safety Action Plan which aims to increase patients safety and drive innovation so that new products are safer, more effective and address the unmet needs of patients.
The FDA is also planning on creating more efficient ways to bring new medical devices to the patients that need them, so we hope to see the level of investment continue and grow in the coming years to help achieve this goal.
Wearable medical devices are beginning to experience rapid growth. Lots of organisations, from leading technology firms to medical device manufacturers, have invested heavily in research in this area and are pushing the boundaries.
High profile companies such as Apple have radically increased the level of interest in wearable devices and they describe their recently launched Apply Watch 4 as “an intelligent guardian for your health”. The device has a number of interesting health monitoring features….. It can alert the wearer of a prolonged elevated heart rate, spot low heart rates and also check for an irregular heart rhythm, notifying the wearer of a potential atrial fibrillation. Later in the year Apple will be releasing a new App for the Watch 4 that will be able to run an FDA-approved electrocardiogram (ECG) test. A study found that the smartwatch could accurately predict atrial fibrillation (AFib) over 98% of the time.
Wearable device research is something that Trulife has also heavily invested in. Earlier this year we launched TruCare – A range of pressurecare that you can wear. The range is highly innovative and it represents a sea-change in pressurecare products.
The complete Trucare range include 4 products:
The range has been created to add protection for the skin and to help prevent pressure injuries from occurring. This new TruCare range can greatly enhance patient’s lives by reducing the risk of injury.
Trulife will continue to drive innovation as it achieves our ultimate goal – improving the life of the patient.
Do you have a question about our products or services? Our dedicated staff is always here to help. Get in touch and we will revert to you as soon as possible. Thank you.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.